1. The powerful anti-inflammatory glucocorticoid triamcinolone acetonide, administered to rats at 20 and 2.5mg/kg, leads to a decrease in the incorporation in vivo of [3H]uridine and [32P]orthophosphate into hind-limb skeletal muscle. 2. At the higher dose, this decrease in the rate of incorporation of precursors into RNA precedes a decrease in the incorporating ability of muscle ribosomes, which commences about 4-5h after drug administration, but is unaccompanied by any changes in the concentration of tissue ATP or free amino acids. 3. The ribosomal dysfunction extends to polyribosomes, which can only be successfully isolated from the muscle of triamcinolone-treated animals after the addition of oc-amylase to the tissue homogenate to remove glycogen. 4. The specific radioactivity of muscle protein labelled in vivo with 14C-labelled amino acids does not decrease progressively after triamcinolone administration. After 2h there is an apparent stimulation of incorporation which leads to an overall discrepancy between measurements of protein-synthetic activity made in vivo and in vitro. 5. There is a significant increase in muscle-glycogen concentration between 8 and 12h after the administration of triamcinolone acetonide (20mg/kg), although a significant decrease occurs after 4h. The fall in glycogen concentration may be due to a decrease in the rate of synthesis of protein essential for glucose uptake into the tissues. 6. As judged by (a) incorporation of 14C-labelled amino acids into protein, (b) [3H]uridine and [32p]_ orthophosphate incorporation into RNA, (c) the rate of induction of tryptophan pyrrolase and (d) changes in the pool sizes of taurine and tryptophan, the responses in liver followed the same time-course as those in muscle after administration of the drug.
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Triamcinolone acetonide is used to produce myopathy in rats as a model for the study of the antimyopathic action of anabolic steroids. In previous studies, skeletal muscle isolated from rats receiving high doses of triamcinolone acetonide possessed decreased ability to incorporate amino acids into protein in vitro (White, 1967;  Bullock, White & Worthington, 1968) . The work described here was designed to examine some of the factors that might be responsible for this decreased ribosomal activity. A preliminary account has appeared (White, Peters, Richardson & Small, 1969) .
MATERIALS AND METHODS
Radioactive compound8. L-[U-14C]Leucine (specific radioactivity 311 mCi/mmol), L-[U-14C]phenylalanine (504mCi/mmol), U-14C-labelled protein hydrolysate (specific radioactivity 54mCi/mg-atom of C), [5-3H] Method of obtaining blood. Animals were killed by decapitation and blood was drained from the neck into tubes containing a small crystal of heparin. Preparation, incubation and analysui ofribosomes. These were prepared from hind-leg muscle. The procedure was either as described for the isolation of P ribosomes from psoas muscle (Bullock et al. 1968) or a modification of this method in which the KCI concentration was changed to 0.25M (Heywood, Dowben & Rich, 1967) during homogenization. The concentrated salt solution added to the post-nuclear supernatant contained 2.0M-KCl and the concentration of salts in the cushioning medium during the final centrifugation was not altered.
To prepare glycogen-free ribosomes, amylase (approx. 620 units) was added to 13ml of the 3000g supernatant and the suspension was keptforlOminatO°C. ac-Amylase (1 unit) frees 1 ,umol of maltose/min from soluble starch at 250C. Subsequent operations were unchanged. Ribosomes were incubated and analysed on continuous sucrose density gradients as described by Bullock et al. (1968) .
Preparation of muscle and liver cell sap and plasma for analysis of amino acid pool sizes. Fresh skeletal muscle (2.0g) was homogenized with the Ultra-Turrax homogenizer for 1 min. in lOml of the medium used for the preparation ofribosomes. Liver was homogenized by using the same proportion of tissue to medium but with a Potter-Elvehjem Teflon homogenizer. The Liver and muscle RNA. This was prepared from lOg of tissue by established procedures (Kirby, 1956 (Kirby, , 1962 . The E260/E280 ratio of the isolated RNA varied between 2.0:1 and 2.2:1.
Phosphorus determination in RNA. The method of Berenblum & Chain was used as modified by Martin & Doty (1949) .
Glycogen. This was determined on 2 ml samples from a solution of 500mg of tissue in 30% (w/v) KOH (5ml) by using anthrone as described by Hassid & Abraham (1957) .
I8olation of protein from muscle and liver for determination of specific radioactivity. Tissue (0.5g) was homogenized in water (5.Oml) by using the Ultra-Turrax at 160V for 1min. Protein was precipitated with 10% (w/v) trichloroacetic acid (20m1) and the mixture was heated for 10min at 900C and centrifuged. The precipitate was washed twice in lOml of ethanol-ether (3:1, v/v) . The protein was dissolved in 2M-NaOH (5ml), reprecipitated with 10% (w/v) trichloroacetic acid (25ml), washed with 5% (w/v) trichloroacetic acid (lOml), heated, centrifuged, washed with ethanol (lOml) and dissolved in 2M-NaOH (2.0ml). The alkaline protein solution was diluted 200-fold for the determination of protein (Lowry, Rosebrough, Farr & Randall, 1951 The radioactivity of RNA labelled with 32p was measured by Cerenkov radiation in lOmm-KH2PO4 by the method of Clausen (1968) by using the 3H channel. The efficiency for counting 32P by this method is about 20%.
RNA labelled with 3H was dissolved in I.Oml of 0.2m-NaOH and its radioactivity measured in lOml of scintillation fluid (Bray, 1960) containing Cab-O-Sil (4%). The counting efficiency for 3H was about 40%.
Protein labelled with 14C from experiments involving labelling in vivo, and from determinations of ribosomal activity, was dissolvedin 2M-NaOH. The radioactivity of the alkaline solution (0.5ml or I.Oml) was measured in scintillation fluid (Bray, 1960) containing Cab-O-Sil (4%). The counting efficiency for 14C was 65%. 8000-10000 counts were accumulated for each sample.
RESULTS
Incorporation of radioactive precursors into protein and RNA. In preliminary experiments with drugtreated and normal animals, the specific radioactivity of protein and RNA from muscle and liver increased for 5h after a single injection of radioactive precursors. To show the correlation between events in muscle and liver at two drug doses, original results are not quoted directly (Figs. 1 and 2) but are related to control values. When triamcinolone acetonide was administered at 2.5mg/kg there was little change in the rate of incorporation of radioactive precursors into protein of liver and muscle ( Fig. 1) , suggesting that rates of protein synthesis in these tissues were not greatly changed. However, there was a large increase of 32p incorporation into liver RNA, which reached a maximum after 6h, and a decrease in the incorporation of 32p into muscle RNA between 2 and 8h after the drug had been given. Weber, Srivastava & Singhal (1965) Glycogen and blood glucose. Glycogen concentration in muscle decreased significantly (P <0.05) 4h after the administration of triamcinolone acetonide (20 mg/kg) and increased significantly to about 2.5 times the control value between 8 and 12h (Fig. 3) . Blood-glucose concentration increased significantly (P<0.05) after 4h. Freeamino acid concentration. In muscle and plasma, the concentrations of individual amino acids were virtually unchanged up to 8h after the ministration of triamcinolone acetonide (20mg/ kg). In liver, the only significant changes were in the concentration of taurine, which increased from 1.2 to 4.5,umol/g oftissue, and in that of tryptophan which decreased from 0.1 to less than 0.03,umol/g of tissue.
Muscle ATP. The mean control concentration from five individual animals was 9.93 (s.E.M. h0.68)
,umol/g. This value decreased insignificantly to 8.83 (s.EmM.+0.34) tmol/g 2h after the administration of triamcinolone acetonide (20mg/kg). ATP concentrations 4, 6, 8 and 12h after the administration of the drug likewise showed no significant change from control values.
Activity and yield of muscle ribosomes. Because of the large increase in muscle glycogen that occurred after the administration of triamcinolone acetonide, we thought that ribosomes isolated from treated animals must be contaminated with glycogen and that this might be the cause of the atypical sucrose density gradient exhibited by these ribosomes (Bullock et al. 1968) , and also the cause of their decreased activity. Ribosomes from animals treated with triamcinolone acetonide (Fig. 4b) (a) showed a broad and slightly retarded monomer peak with no discrete peaks over the remaining part of the gradient. However, by treating another batch of the same post-nuclear supernatant with amylase, we prepared ribosomes with a sucrose-densitygradient profile (Fig. 4c) indistinguishable from that ofthe control (Fig. 4a ) but still with decreased amino acid-incorporating ability (Table 2) . When the incorporating abilities of amylase-treated ribosomes from muscle of control and triamcinolone-treated animals were compared after fractionation through a discontinuous sucrose density gradient the differences in their relative activities were retained (Table 2) . Since the same cell sap was used for control and test ribosomes this difference in amino acid-incorporating ability was not due to pool size differences or to differential rates of charging to tRNA. The low activity of ribosomes from the triamcinolone-treated animals was not due to a low polyribosome/monoribosome ratio, since the activity differential was retained in ribosomes that sedimented through 1.5M-sucrose and that therefore contained virtually no single ribosomes (Wettstein, Staehelin & Noll, 1963) .
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In all the experiments in which 0.25m-potassium chloride was used in the isolation of ribosomes the yield of ribosomal RNA/g wet wt. of tissue ranged between 60 and 130,g. Previously, Bullock et al. (1968) found that the normal yield of P ribosomes varied between 20 and 40,ug of ribosomal RNA/g wet wt. of tissue. There was no evidence that triamcinolone acetonide treatment resulted in a decreased yield of muscle ribosomes or polyribosomes (Table 2) .
Tryptophan metabolism. Tryptophan pyrrolase activity in the liver increased extremely rapidly after the administration of triamcinolone acetonide (Table 3 ) and this increase was accompanied by a decrease in the size of the liver tryptophan pool mentioned above. No changes in muscle or blood tryptophan concentrations were detected over the 4h period. These results suggest that the increase in liver tryptophan pyrrolase activity is not induced by the entry of tryptophan into liver from muscle, a possibility arising from the demonstration by Labrie & Korner (1968) that the administration of tryptophan to adrenalectomized animals causes a significant actinomycin-sensitive increase in the activity of liver tryptophan pyrrolase. It appears that tryptophan pyrrolase activity is limiting for tryptophan metabolism and that the increased rate of breakdown of the amino acid after the increase in enzyme activity causes its concentration to be decreased in the tissue extract.
DISCUSSION
The experiments on the incorporating ability of isolated muscle ribosomes have extended previous findings (Bullock et al. 1968) . It was shown that the decrease in their activity that becomes significant 4-5h after the administration of the glucocorticoid, triamcinolone acetonide, is neither due to the contamination of the ribosomes with glycogen nor to an Bioch. 1970, 116 (% of control) 100 84 100 77 100 74 increase in their monoribosome/polyribosome ratio, since ribosomes that contain predominantly polyribosomes still differ appreciably in activity from control polyribosomes. Changes in the overall energy content of the tissue (Manchester & Young, 1959; Manchester, 1966) , as judged by the ATP concentration, also seem unlikely to be the cause of the ribosomal dysfunction. Liver protein synthesis is influenced at the ribosomal level by the flow of amino acids to the liver (for references see Jefferson & Korner, 1969) . Since significant changes in the pool size of a number of amino acids occur in muscle 4h after the administration of cortisone to starved adrenalectomized rats (Betheil, Feigelson & Feigelson, 1965) it was thought that changes in amino acid-pool sizes in muscle after triamcinolone acetonide administration might lead to the decrease in ribosomal activity. Again this seems an unlikely mechanism, since activities of free amino acids in tissue extracts were virtually unchanged 8h after the administration of the drug.
Since there was a decrease in the rate ofincorpora- (Wool & Weinshelbaum, 1959) . More work is indicated on the eaxly effects of corticosteroids on nuclear metabolism in muscle, but because of the high degree of contamination with various species of adenosine triphosphatase we failed to demonstrate changes in the activity of RNA polymerase in isolated nuclei.
The changes in the specific radioactivity of pulselabelled muscle protein after triamcinolone administration show the total effect ofthe drug on ribosomal activity, the number of active ribosomes and the rate of uptake of amino acids into the tissue. We therefore expected this method of labelling protein to show a greater percentage decrease in the specific radioactivity of muscle protein than that seen in the protein made by ribosomes in vitro. However, this was not so, owing to a big discrepancy after 2h, when there appeared to be a stimulation of amino acid incorporation in vivo and no change in vitro.
There was no decrease in the pool size of free amino acids over the first 8h of triamcinolone acetonide treatment, so that within the tissue the specific radioactivity of amino acids entering the protein could be expected to be the same in control and drug-treated animals. At present we cannot explain this lack of agreement. Since the hepatic output of glucose is decreased immediately after glucocorticoid administration (Lecocq, Mebane & Madison, 1964) , the increase in blood glucose concentration implies a decrease in the uptake of glucose by peripheral tissue beginning about 4h after the administration of triamcinolone acetonide. Ofthese peripheral tissues adipose tissue is almost certainly affected over this time (Munck & Koritz, 1962; Munck, 1962) , as judged by the administration of cortisol in vivo to adrenalectomized rats, but this effect might not apply to muscle. However, the fact that muscle glycogen concentration falls significantly 4h after the administration of triamcinolone acetonide suggests that glucose uptake into muscle is decreased after treatment with this more powerful glucocorticoid. The entry of glucose into the muscle cell follows MichaelisMenten kineties (Morgan, Henderson, Regen & Park, 1961) , indicating the initial binding of glucose to a specific membrane site. If this site contains a protein that is rapidly turning over, then a decrease in the amount of this protein due to a general decrease in protein synthesis would lower the rate of glucose entry into the cell. The timing of the effect of triamcinolone on muscle protein synthesis suggests that inhibition of glucose uptake may be a result and not a cause of it. Evidence for a similar mechanism by which amino acid uptake into muscle is diminished by corticosteroids was found by Kostyo & Redmond (1966) , who showed that puromycin and actinomycin D are corticomimetic in that they inhibit the uptake of amino acids into isolated diaphragm in vitro after 2-3h.
Skeletal muscle is generally thought to be nonglyconeogenic (Scrutton & Utter, 1968) , and the increase in glycogen concentration that occurs in this tissue between 8 and 12h after the administration of triamoinolone acetonide is almost certainly due to the inhibition of glucose utilization. Among the most likely causes of decreased glycolysis is a rise in the tissue concentration of metabolites from the increased oxidation of free fatty acids (Randle, Newsholme & Garland, 1964; Williamson, 1967) . Fatty acids would be expected to be mobilized rapidly from adipose tissue by triamcinolone.
The effects that glucocorticoids are capable of exerting on amino acid uptake in isolated diaphragm (Kostyo, 1965) suggest that muscle can respond directly to glucocorticoids. However, the pronounced changes in liver metabolism caused by these compounds indicate that it mray be impossible to understand their physiological effects completely without considering the liver. This was realized previously in studies of the mechanism of thymus involution (Feigelson, 1965; Hofert &; and to some extent in studies on muscle (Betheil et al. 1965; Uete, 1966a,b) . However, our results provide no evidence for a time lag between events taking place in liver and muscle and indicate that the two tissues respond to the drug equally quickly. The increases in liver tryptophan pyrrolase activity and incorporation ofprecursors into liver RNA start almost immediately after the administration of the steroid, as does the decrease in the incorporation of RNA precursors into muscle. Thus this glucocorticoid could affect many sites simultaneously. One of these sites may be the nuclear mechanism for the production of muscle RNA and ribosomal activity may fall because of this interaction.
